This tool looks for unlabeled Wikidata items in your language. It starts with a Wikidata item,
looks at all the associated Wikipedia pages, the links on all those pages, and lists the Wikidata items corresponding to the link targets.
Q7166532 - peptide vaccine
Searching link targets on 5 Wikipedias...
Item | Label [en] | Wikilabels | Link # |
---|---|---|---|
Q172847 [CC | ] | peptide | Peptide | Peptid | Pèptid | ペプチド | പെപ്റ്റൈഡ് | 5 |
Q103537 [CC | ] | antigen | Antigen | 抗原 | 3 |
Q128711 [CC | ] | epitope | Epitope | Epitop | エピトープ | 3 |
Q11954166 [CC | ] | subunit vaccine | Subunit vaccine | サブユニットワクチン | സബ്യൂണിറ്റ് വാക്സിൻ | 3 |
Q134808 [CC | ] | vaccine | Vaccine | Impfstoff | ワクチン | 3 |
Q42982 [CC | ] | allergy | Allergy | アレルギー | 2 |
Q283399 [CC | ] | alpha helix | Alpha helix | Αヘリックス | 2 |
Q11081 [CC | ] | Alzheimer's disease | Alzheimer's disease | アルツハイマー病 | 2 |
Q1810913 [CC | ] | attenuated vaccine | Attenuated vaccine | Lebendimpfstoff | 2 |
Q188930 [CC | ] | B-cell | B cell | B細胞 | 2 |
Q2378309 [CC | ] | cancer vaccine | Cancer vaccine | がんワクチン | 2 |
Q273499 [CC | ] | chemical synthesis | Chemical synthesis | 化学合成 | 2 |
Q1812946 [CC | ] | cholera vaccine | Cholera vaccine | കോളറ വാക്സിൻ | 2 |
Q98947046 [CC | ] | EpiVacCorona | EpiVacCorona | 2 |
Q282142 [CC | ] | glioblastoma | Glioblastoma | 膠芽腫 | 2 |
Q19161 [CC | ] | hemagglutinin | Hemagglutinin | ヘマグルチニン | 2 |
Q708693 [CC | ] | Hepatitis C virus | Hepatitis C virus | C型肝炎ウイルス | 2 |
Q5958765 [CC | ] | hypersensitivity | Hypersensitivity | 過敏症 | 2 |
Q1415366 [CC | ] | immunization | Immunization | 免疫化 | 2 |
Q221681 [CC | ] | in vitro experiment | In vitro | 2 |
Q166231 [CC | ] | infection | Infection | 感染 | 2 |
Q2840 [CC | ] | influenza | Influenza | インフルエンザ | 2 |
Q419245 [CC | ] | nucleoprotein | Nucleoprotein | 核タンパク質 | 2 |
Q110820614 [CC | ] | peptide synthesis | Peptide synthesis | Peptidsynthese | 2 |
Q904984 [CC | ] | protein secondary structure | Protein secondary structure | 二次構造 | 2 |
Q193529 [CC | ] | T-lymphocytes | T cell | T細胞 | 2 |
Q632518 [CC | ] | T helper cell | T helper cell | T-Helferzelle | 2 |
Q357896 [CC | ] | adjuvant | Adjuvans | アジュバント | 2 |
Q25670 [CC | ] | digital object identifier | Digital Object Identifier | DOI | 2 |
Q8054 [CC | ] | protein | Protein | タンパク質 | 2 |
Q170065 [CC | ] | pathogen | Patogen | 病原体 | 2 |
Q898701 [CC | ] | 2009 flu pandemic vaccine | 2009 swine flu pandemic vaccine | 1 |
Q4652456 [CC | ] | ALVAC-CEA vaccine | ALVAC-CEA vaccine | 1 |
Q3242415 [CC | ] | ATC code J07 | ATC code J07 | 1 |
Q4682307 [CC | ] | adenovirus vaccine | Adenovirus vaccine | 1 |
Q4686835 [CC | ] | Advisory Committee on Immunization Practices | Advisory Committee on Immunization Practices | 1 |
Q19903264 [CC | ] | Alternative vaccination schedule | Alternative vaccination schedule | 1 |
Q28209771 [CC | ] | Androvax | Androvax | 1 |
Q4007170 [CC | ] | anthrax vaccine | Anthrax vaccine | 1 |
Q3631833 [CC | ] | artificial induction of immunity | Artificial induction of immunity | 1 |
Q798309 [CC | ] | BCG vaccine | BCG vaccine | 1 |
Q4007174 [CC | ] | Brucellosis vaccine | Brucellosis vaccine | 1 |
Q87719492 [CC | ] | COVID-19 vaccine | COVID-19 vaccine | 1 |
Q17007160 [CC | ] | Cedillo v. Secretary of Health and Human Services | Cedillo v. Secretary of Health and Human Services | 1 |
Q2575335 [CC | ] | Cervarix | Cervarix | 1 |
Q123385957 [CC | ] | Chikungunya vaccine | Chikungunya vaccine | 1 |
Q30612 [CC | ] | clinical trial | Clinical trial | 1 |
Q574905 [CC | ] | Clostridioides difficile colitis | Clostridioides difficile infection | 1 |
Q5161160 [CC | ] | conjugate vaccine | Conjugate vaccine | 1 |
Q96695265 [CC | ] | Ad5-nCoV | Convidecia | 1 |
Q106350062 [CC | ] | Corbevax | Corbevax | 1 |
Q97154233 [CC | ] | CoronaVac | CoronaVac | 1 |
Q98703813 [CC | ] | Covaxin / BBV152 | Covaxin | 1 |
Q5201363 [CC | ] | Cytomegalovirus vaccine | Cytomegalovirus vaccine | 1 |
Q578537 [CC | ] | DNA vaccine | DNA vaccine | 1 |
Q908600 [CC | ] | DPT vaccine | DPT vaccine | 1 |
Q55608806 [CC | ] | DTaP-IPV-HepB vaccine | DTaP-IPV-HepB vaccine | 1 |
Q55608807 [CC | ] | DTaP-IPV/Hib vaccine | DTaP-IPV/Hib vaccine | 1 |
Q123002456 [CC | ] | DTwP-HepB-Hib vaccine | DTwP-HepB-Hib vaccine | 1 |
Q18388297 [CC | ] | dengue vaccine | Dengue vaccine | 1 |
Q4007175 [CC | ] | diphtheria vaccine | Diphtheria vaccine | 1 |
Q88608402 [CC | ] | Drew Weissman | Drew Weissman | 1 |
Q3553092 [CC | ] | Ebola vaccine | Ebola vaccine | 1 |
Q40852 [CC | ] | Edward Jenner | Edward Jenner | 1 |
Q133805 [CC | ] | epidemiology | Epidemiology | 1 |
Q5384030 [CC | ] | Epstein–Barr vaccine | Epstein–Barr virus vaccine | 1 |
Q1347969 [CC | ] | eradication of infectious diseases | Eradication of infectious diseases | 1 |
Q688592 [CC | ] | GAVI | GAVI | 1 |
Q2643555 [CC | ] | Gardasil | Gardasil | 1 |
Q27547678 [CC | ] | Amino acid starvation-responsive transcription factor GCN4 YEL009C | Gcn4 | 1 |
Q3500350 [CC | ] | Group B streptococcal infection | Group B streptococcal infection | 1 |
Q118226 [CC | ] | growth factor receptor | Growth factor receptor | 1 |
Q71050949 [CC | ] | H. Fred Clark | H. Fred Clark | 1 |
Q5628867 [CC | ] | H5N1 vaccine | H5N1 vaccine | 1 |
Q1479804 [CC | ] | HIV vaccine | HIV vaccine development | 1 |
Q900189 [CC | ] | HPV vaccine | HPV vaccine | 1 |
Q17138123 [CC | ] | Hantavirus vaccine | Hantavirus vaccine | 1 |
Q578994 [CC | ] | parasitic helminthiasis infectious disease | Helminthiasis | 1 |
Q17066597 [CC | ] | Twinrix | Hepatitis A and B vaccine | 1 |
Q3553093 [CC | ] | hepatitis A vaccine | Hepatitis A vaccine | 1 |
Q117749 [CC | ] | Hepatitis B vaccine | Hepatitis B vaccine | 1 |
Q17152553 [CC | ] | hepatitis C vaccine | Hepatitis C vaccine | 1 |
Q326643 [CC | ] | hepatitis E | Hepatitis E | 1 |
Q5743645 [CC | ] | Herpes simplex research | Herpes simplex research | 1 |
Q5747312 [CC | ] | heterologous vaccine | Heterologous vaccine | 1 |
Q794717 [CC | ] | hexavalent vaccine | Hexavalent vaccine | 1 |
Q368134 [CC | ] | Hib vaccine | Hib vaccine | 1 |
Q936389 [CC | ] | Hilary Koprowski | Hilary Koprowski | 1 |
Q12212063 [CC | ] | hookworm | Hookworm | 1 |
Q5898177 [CC | ] | hookworm vaccine | Hookworm vaccine | 1 |
Q79455 [CC | ] | immunoglobulin E | Immunoglobulin E | 1 |
Q79448 [CC | ] | immunoglobulin G | Immunoglobulin G | 1 |
Q967453 [CC | ] | immunologic adjuvant | Immunologic adjuvant | 1 |
Q3560939 [CC | ] | inactivated vaccine | Inactivated vaccine | 1 |
Q383260 [CC | ] | influenza vaccine | Influenza vaccine | 1 |
Q1664296 [CC | ] | inoculation | Inoculation | 1 |
Q98655215 [CC | ] | Ad26.COV2.S | Janssen COVID-19 vaccine | 1 |
Q4007171 [CC | ] | Japanese encephalitis vaccine | Japanese encephalitis vaccine | 1 |
Q312961 [CC | ] | John Franklin Enders | John Franklin Enders | 1 |
Q200101 [CC | ] | Jonas Salk | Jonas Salk | 1 |
Q88608397 [CC | ] | Katalin Karikó | Katalin Karikó | 1 |
Q1496686 [CC | ] | Keyhole limpet hemocyanin | Keyhole limpet hemocyanin | 1 |
Q65119129 [CC | ] | Lancet MMR autism fraud | Lancet MMR autism fraud | 1 |
Q155098 [CC | ] | leptospirosis | Leptospirosis | 1 |
Q6644530 [CC | ] | list of vaccine ingredients | List of vaccine excipients | 1 |
Q6644529 [CC | ] | list of vaccine topics | List of vaccine topics | 1 |
Q217094 [CC | ] | list of withdrawn drugs | List of withdrawn drugs | 1 |
Q2043512 [CC | ] | live attenuated influenza vaccine | Live attenuated influenza vaccine | 1 |
Q529 [CC | ] | Louis Pasteur | Louis Pasteur | 1 |
Q201989 [CC | ] | Lyme disease | Lyme disease | 1 |
Q908104 [CC | ] | MMR vaccine | MMR vaccine | 1 |
Q10862691 [CC | ] | MMR vaccine controversy | MMR vaccine and autism | 1 |
Q6716846 [CC | ] | MMRV vaccine | MMRV vaccine | 1 |
Q85795487 [CC | ] | RNA vaccine | MRNA vaccine | 1 |
Q6741353 [CC | ] | malaria vaccine | Malaria vaccine | 1 |
Q990044 [CC | ] | epidemiological modeling | Mathematical modelling of infectious diseases | 1 |
Q983898 [CC | ] | Maurice Hilleman | Maurice Hilleman | 1 |
Q17149595 [CC | ] | MeNZB | MeNZB | 1 |
Q6804161 [CC | ] | measles vaccine | Measles vaccine | 1 |
Q180614 [CC | ] | melanoma | Melanoma | 1 |
Q6817090 [CC | ] | meningococcal vaccine | Meningococcal vaccine | 1 |
Q87775025 [CC | ] | mRNA-1273 vaccine | Moderna COVID-19 vaccine | 1 |
Q6935478 [CC | ] | mumps vaccine | Mumps vaccine | 1 |
Q11789728 [CC | ] | National Childhood Vaccine Injury Act | National Childhood Vaccine Injury Act | 1 |
Q85787927 [CC | ] | National Immunization Technical Advisory Group | National Immunization Technical Advisory Group | 1 |
Q7907951 [CC | ] | National Vaccine Injury Compensation Program | National Vaccine Injury Compensation Program | 1 |
Q2433913 [CC | ] | Necator americanus | Necator americanus | 1 |
Q9049868 [CC | ] | NicVAX | NicVAX | 1 |
Q7042682 [CC | ] | NmVac4-A/C/Y/W-135 | NmVac4-A/C/Y/W-135 | 1 |
Q97154235 [CC | ] | NVX-CoV2373 | Novavax COVID-19 vaccine | 1 |
Q28209758 [CC | ] | Ovandrotone albumin | Ovandrotone albumin | 1 |
Q95042269 [CC | ] | AZD1222 | Oxford–AstraZeneca COVID-19 vaccine | 1 |
Q1353540 [CC | ] | Pandemrix | Pandemrix | 1 |
Q7152812 [CC | ] | Paul A. Offit | Paul Offit | 1 |
Q7170955 [CC | ] | pertussis vaccine | Pertussis vaccine | 1 |
Q97154240 [CC | ] | Pfizer–BioNTech COVID-19 vaccine | Pfizer–BioNTech COVID-19 vaccine | 1 |
Q7180990 [CC | ] | phase of clinical research | Phases of clinical research | 1 |
Q4007173 [CC | ] | plague vaccine | Plague vaccine | 1 |
Q7205991 [CC | ] | pneumococcal conjugate vaccine | Pneumococcal conjugate vaccine | 1 |
Q2100023 [CC | ] | pneumococcal polysaccharide vaccine | Pneumococcal polysaccharide vaccine | 1 |
Q14538008 [CC | ] | pneumococcal vaccine | Pneumococcal vaccine | 1 |
Q1519099 [CC | ] | polio vaccine | Polio vaccine | 1 |
Q925645 [CC | ] | pox party | Pox party | 1 |
Q25091283 [CC | ] | Prostvac | Prostvac | 1 |
Q735188 [CC | ] | protein structure | Protein structure | 1 |
Q164818 [CC | ] | Q fever | Q fever | 1 |
Q7277881 [CC | ] | RTS,S | RTS,S | 1 |
Q18085856 [CC | ] | VSV-EBOV | RVSV-ZEBOV vaccine | 1 |
Q4007169 [CC | ] | rabies vaccine | Rabies vaccine | 1 |
Q96401585 [CC | ] | Respiratory syncytial virus vaccine | Respiratory syncytial virus vaccine | 1 |
Q25104603 [CC | ] | rindopepimut | Rindopepimut | 1 |
Q4411598 [CC | ] | rotavirus vaccine | Rotavirus vaccine | 1 |
Q7375928 [CC | ] | rubella vaccine | Rubella vaccine | 1 |
Q106265257 [CC | ] | Sanofi–GSK COVID-19 vaccine | Sanofi–GSK COVID-19 vaccine | 1 |
Q2903025 [CC | ] | Schistosomiasis vaccine | Schistosomiasis vaccine | 1 |
Q327298 [CC | ] | shigellosis | Shigellosis | 1 |
Q97154230 [CC | ] | BBIBP-CorV | Sinopharm BIBP COVID-19 vaccine | 1 |
Q108044254 [CC | ] | SKYCovione | Skycovione | 1 |
Q1037810 [CC | ] | smallpox vaccine | Smallpox vaccine | 1 |
Q98270627 [CC | ] | Gam-COVID-Vac | Sputnik V COVID-19 vaccine | 1 |
Q7599873 [CC | ] | Stanley Plotkin | Stanley Plotkin | 1 |
Q104857865 [CC | ] | Strategic Advisory Group of Experts | Strategic Advisory Group of Experts | 1 |
Q7662786 [CC | ] | synthetic vaccine | Synthetic vaccine | 1 |
Q7669135 [CC | ] | TA-CD | TA-CD | 1 |
Q7669132 [CC | ] | TA-NIC | TA-NIC | 1 |
Q5861101 [CC | ] | tetanus vaccine | Tetanus vaccine | 1 |
Q85809000 [CC | ] | therapeutic vaccines | Therapeutic vaccines | 1 |
Q3689384 [CC | ] | Thiomersal and vaccines | Thiomersal and vaccines | 1 |
Q7800618 [CC | ] | tick-borne encephalitis vaccine | Tick-borne encephalitis vaccine | 1 |
Q2967192 [CC | ] | timeline of vaccines | Timeline of human vaccines | 1 |
Q908822 [CC | ] | toxoid | Toxoid | 1 |
Q7848585 [CC | ] | trypanosomiasis vaccine | Trypanosomiasis vaccine | 1 |
Q7850848 [CC | ] | tuberculosis vaccines | Tuberculosis vaccines | 1 |
Q7859567 [CC | ] | Ty21a | Ty21a | 1 |
Q7861081 [CC | ] | typhoid vaccine | Typhoid vaccine | 1 |
Q7861366 [CC | ] | typhus vaccine | Typhus vaccine | 1 |
Q5417450 [CC | ] | Every Child By Two | Vaccinate Your Family | 1 |
Q192995 [CC | ] | vaccination | Vaccination | 1 |
Q7907936 [CC | ] | vaccination policy | Vaccination policy | 1 |
Q1644301 [CC | ] | vaccination schedule | Vaccination schedule | 1 |
Q7907943 [CC | ] | Vaccine Adverse Event Reporting System | Vaccine Adverse Event Reporting System | 1 |
Q7907949 [CC | ] | Vaccine Safety Datalink | Vaccine Safety Datalink | 1 |
Q445335 [CC | ] | vaccine adverse event | Vaccine adverse event | 1 |
Q56641686 [CC | ] | vaccine hesitancy | Vaccine hesitancy | 1 |
Q106520117 [CC | ] | vaccine ingredient | Vaccine ingredients | 1 |
Q106522066 [CC | ] | Vaccine storage | Vaccine storage | 1 |
Q7907956 [CC | ] | vaccine trial | Vaccine trial | 1 |
Q107299151 [CC | ] | Vaccine wastage | Vaccine wastage | 1 |
Q65118777 [CC | ] | Vaccines and SIDS | Vaccines and SIDS | 1 |
Q7907958 [CC | ] | Vaccines for Children Program | Vaccines for Children Program | 1 |
Q104902499 [CC | ] | Valneva COVID-19 vaccine | Valneva COVID-19 vaccine | 1 |
Q2721987 [CC | ] | varicella vaccine | Varicella vaccine | 1 |
Q7924335 [CC | ] | Vi capsular polysaccharide vaccine | Vi capsular polysaccharide vaccine | 1 |
Q1475781 [CC | ] | virus-like particle | Virus-like particle | 1 |
Q37155 [CC | ] | World Health Organization Model List of Essential Medicines | WHO Model List of Essential Medicines | 1 |
Q8051876 [CC | ] | yellow fever vaccine | Yellow fever vaccine | 1 |
Q24657950 [CC | ] | Zika fever vaccine | Zika virus vaccine | 1 |
Q8074572 [CC | ] | herpes zoster vaccine | Zoster vaccine | 1 |
Q425105 [CC | ] | amino acid sequence | Aminosäuresequenz | 1 |
Q758000 [CC | ] | attenuation | Attenuierung | 1 |
Q1577018 [CC | ] | Hans-Georg Rammensee | Hans-Georg Rammensee | 1 |
Q423163 [CC | ] | major histocompatibility complex | Haupthistokompatibilitätskomplex | 1 |
Q1660181 [CC | ] | immunogen | Immunogen | 1 |
Q15824190 [CC | ] | No label in en! | Kontamination (Medizin) | 1 |
Q426454 [CC | ] | Mimotope | Mimotop | 1 |
Q373217 [CC | ] | recombinant protein | Rekombinantes Protein | 1 |
Q898597 [CC | ] | cross-linking | Vernetzung (Chemie) | 1 |
Q7935312 [CC | ] | Virus processing | Virusinaktivierung | 1 |
Q189082 [CC | ] | cell culture | Zellkultur | 1 |
Q12078 [CC | ] | cancer | Càncer | 1 |
Q131276 [CC | ] | International Standard Serial Number | ISSN | 1 |
Q180686 [CC | ] | PubMed | PubMed | 1 |
Q33057 [CC | ] | International Standard Book Number | ISBN | 1 |
Q82069695 [CC | ] | SARS-CoV-2 | SARSコロナウイルス2 | 1 |
Q8066 [CC | ] | amino acid | アミノ酸 | 1 |
Q7430 [CC | ] | DNA | デオキシリボ核酸 | 1 |
Q172778 [CC | ] | plasmid | プラスミド | 1 |
Q908725 [CC | ] | Merrifield synthesis | ペプチド固相合成法 | 1 |
Q899763 [CC | ] | protein primary structure | 一次構造 | 1 |
Q424401 [CC | ] | epidermal growth factor receptor | 上皮成長因子受容体 | 1 |
Q1660197 [CC | ] | immunogenicity | 免疫原性 | 1 |
Q1612119 [CC | ] | immune response | 免疫応答 | 1 |
Q583851 [CC | ] | Native state | 天然状態 | 1 |
Q376266 [CC | ] | cytotoxic T cell | 細胞傷害性T細胞 | 1 |
Q189146 [CC | ] | cell-mediated immunity | 細胞性免疫 | 1 |
Q1860 [CC | ] | English | 英語 | 1 |
Q26972 [CC | ] | gene expression | 遺伝子発現 | 1 |